13F Holdings
中文EN

PYPD PolyPid Ltd.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1611842 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY—
TTM net income YoY-17.7%
TTM EPS YoY-57.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-366.3%
ROA-143.8%
ROIC (approx.)-1,290.9%
Asset turnover—

Leverage & solvency

Liabilities / assets50.8%
Debt / equity0.00x
Current ratio1.97x
Interest coverage-37.72x

Cash quality & payout

Operating cash flow / net income0.82x
Accruals ratio-26.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue—————
R&D expense$23.81M$22.81M$16.15M$27.99M$30.55M
SG&A expense$7.18M$4.27M$5.52M$8.01M$9.61M
Operating income-$32.97M-$28.03M-$22.87M-$38.89M-$43.15M
Interest expense$874,000$1.51M$1.62M$1.02M—
Pretax income-$34.16M-$28.98M-$23.80M-$39.43M-$42.60M
Income tax$5,000$42,000$69,000$129,000—
Net income-$34.17M-$29.02M-$23.86M-$39.56M-$42.60M
EBITDA-$31.51M-$26.41M-$21.05M-$37.17M-$42.03M
EPS (basic)2.094.9116.9961.0968.27
EPS (diluted)2.094.9116.9361.0968.27
Weighted avg. shares (diluted)16.35M5.91M1.42M647,556624,051
Balance sheet
Cash & equivalents$6.40M$15.64M$5.31M$9.14M$10.46M
Current assets$15.23M$16.57M$6.07M$14.19M$34.81M
PP&E, net$5.09M$6.08M$7.62M$9.25M$8.76M
Total assets$22.31M$25.22M$15.37M$25.97M$44.23M
Current liabilities$7.74M$12.68M$7.29M$8.55M$8.08M
Short-term debt$988,000$6.79M$4.00M$4.02M—
Long-term debt—$634,000$6.38M$7.57M—
Total debt—$7.42M$10.38M$11.60M—
Total liabilities$11.33M$17.54M$17.47M$20.14M$8.28M
Shareholders' equity$10.97M$7.68M-$2.10M$5.83M$35.96M
Net debt—-$8.22M$5.07M$2.46M—
Shares outstanding18.20M10.19M1.65M669,60518.76M
Cash flow statement
Operating cash flow-$27.88M-$21.96M-$17.24M-$34.32M-$32.39M
Capital expenditure$210,000$76,000$196,000$1.77M$2.65M
Free cash flow-$28.09M-$22.04M-$17.43M-$36.08M-$35.04M
Investing cash flow-$6.70M-$330,000$3.80M$16.57M$36.90M
Financing cash flow$25.37M$32.42M$9.98M$16.43M$1.03M
Depreciation & amortization$1.46M$1.62M$1.82M$1.72M$1.12M
Stock-based compensation$4.85M$2.82M$3.39M$4.31M$4.75M

Free plan shows the latest 5 periods; Pro shows all 8 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.